Novo Nordisk Foundation
Regenerative Medicine Catalyst Grants
Two-phase process; Phase I concept note deadline not specified. Webinar on 4 August 2026. Grants awarded over 2026–2027.
Last verified:
Details
| Funder | Novo Nordisk Foundation |
| Budget | Up to DKK 5M (standard) / Up to DKK 10M (collaborative); total pool DKK 100M |
| Deadline | 1 September 2026 |
| Duration | Up to 3 years |
| Consortium | No (optional for standard; required for collaborative projects — at least 1 international co-applicant from a different country) |
| Application | 2-stage: Phase I concept note → Phase II full application with external peer review |
| Eligible countries | DKSENOFIISGLFO |
Eligibility & scope
Main applicant must be an established investigator at a university, hospital, or non-profit research institution in a Nordic country (Denmark, Sweden, Norway, Finland, Iceland, Greenland, Faroe Islands). Translational/applied focus on stem cell-based therapies across four themes: allogeneic cell therapy, analytical methods, biomaterials, and clinical development. Fundamental discovery, adult immune cell (CAR-T/NK), and gene therapy projects are out of scope. For-profit partners may collaborate but cannot receive direct funding.
More from Novo Nordisk Foundation
Data Science Investigator Programme
Deadline: 15 Jul 2026Up to DKK 14.7M per grantNovo Nordisk Foundation Data Science Investigator Programme 2026
Deadline: 15 Jul 2026Up to DKK 14.7M (~€1.97M)Data Science Investigator Programme 2026
Deadline: 15 Jul 2026Up to DKK 14.7 million per grantNexa Innovation Call: Innovations that reduce the impact of heat on people living with cardiometabolic diseases in Africa
Deadline: 22 Jul 2026Novonesis Biotechnology Prize
Deadline: 1 Aug 20265 Million DKK
Browse Related
Could Regenerative Medicine Catalyst Grants be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →